Search Results - "dynamic causal modelling"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Subject Terms: Parkinson's disease, dopaminergic neurons, substantia nigra, ψ–Hamzah Model, Hamzah Equation, neurodegeneration, α-synuclein, mitochondrial dysfunction, neuroinflammation, apoptosis inhibition, neuroregeneration, dopaminergic pathways, pharmacokinetics, pharmacodynamics, fractional calculus, fractal dynamics, stochastic modelling, integral equations, neuronal plasticity, synaptic restoration, neuroprotection, dopamine transporters, basal ganglia, LRRK2 mutation, SNCA mutation, PARK7 mutation, PINK1 mutation, PRKN mutation, GBA mutation, gene therapy, nanoparticle vaccine, nanomedicine, neuropharmacology, multiscale modelling, clinical simulation, drug resistance, computational neuroscience, biophysical modelling, PK/PD analysis, differential equations, systems biology, neurocognitive modelling, neuronal apoptosis, neurovascular coupling, glial activation, oxidative stress, free radicals, mitochondrial biogenesis, synaptic dysfunction, vesicular transport, Lewy bodies, clinical trial simulation, neural dynamics, fractional derivative, fractal integral, noise modelling, quantum biology, bioinformatics, machine learning, predictive modelling, multiomics integration, proteomics, genomics, transcriptomics, metabolomics, biomarker discovery, imaging biomarkers, PET scan, fMRI, diffusion MRI, deep brain stimulation, neuromodulation, neurocircuitry, basal ganglia-thalamocortical loop, motor control, tremor reduction, rigidity suppression, bradykinesia, neurorehabilitation, neurogenesis, stem cell therapy, CRISPR-Cas9, optogenetics, pharmacogenomics, neuroadaptive plasticity, inflammation suppression, IL-10 agonist, Bcl-2 agonist, peptide therapeutics, lipid nanoparticles, PEGylation, liposomal delivery, controlled release, drug targeting, nanocarrier design, exosome delivery, quantum peptides, bioreactor design, stirred-tank reactor, PID control, lyophilisation, cryopreservation, stability testing, ICH Q8, ICH Q9, ICH Q10, quality control, HPLC analysis, Western blot, ELISA assay, flow cytometry, toxicity assay, MTT assay, sterility testing, immunogenicity, cross-species validation, in vitro testing, in vivo testing, animal models, humanised mouse models, primate models, clinical translation, phase I trials, phase II trials, phase III trials, meta-analysis, systematic review, clinical outcomes, efficacy, safety, tolerability, dose optimisation, pharmacovigilance, adverse effect minimisation, personalised medicine, precision medicine, multi-agent therapy, combination therapy, AI-driven drug design, deep learning, neural networks, reinforcement learning, cognitive modelling, decision trees, random forests, support vector machines, gradient boosting, PCA, clustering, dimensionality reduction, Sobol sequences, Monte Carlo simulation, stochastic differential equations, agent-based modelling, network analysis, graph theory, connectivity mapping, brain networks, connectome, dynamic causal modelling, Bayesian inference, probabilistic modelling, big data neuroscience, high-performance computing, parallel processing, GPU acceleration, quantum computing, cloud computing, distributed systems, Zarr storage, parquet datasets, large-scale simulation, trillion-scenario modelling, reproducibility, statistical validation, t-test, binomial test, chi-square test, confidence intervals, effect size, significance testing, error minimisation, uncertainty quantification, robustness analysis, sensitivity analysis, parameter optimisation, differential evolution, genetic algorithms, swarm intelligence, fractal noise, chaotic dynamics, entropy analysis, Lyapunov exponents, stability landscapes, attractor states, bifurcation analysis, oscillatory dynamics, phase synchronisation, coherence analysis, cross-frequency coupling, theta-gamma coupling, beta oscillations, gamma oscillations, tremor oscillations, electrophysiology, EEG, MEG, invasive recordings, spike sorting, neuronal firing, ion channels, calcium imaging, voltage-sensitive dyes, optogenetic stimulation, chemogenetics, neurofeedback, closed-loop systems, prosthetic interfaces, brain-computer interface, neuromorphic computing, silicon neurons, memristors, artificial synapses, nanowire networks, biohybrid systems, synthetic biology, cellular reprogramming, induced pluripotent stem cells, differentiation pathways, neuronal lineage, astrocyte modulation, microglial modulation, oligodendrocyte function, myelination, remyelination, axonal regeneration, dendritic spines, synaptic vesicles, neurotransmitter release, reuptake inhibition, MAO-B inhibition, COMT inhibition, dopamine agonists, levodopa, carbidopa, amantadine, selegiline, rasagiline, safinamide, entacapone, tolcapone, ropinirole, pramipexole, apomorphine, rotigotine, istradefylline, amantadine ER, adenosine A2A antagonists, glutamate modulators, GABAergic modulation, cholinergic pathways, serotonergic pathways, noradrenergic modulation, cannabinoid signalling, endocannabinoids, CB1 receptor, CB2 receptor, TRPV1, neuropeptides, orexin, substance P, dynorphin, enkephalin, β-endorphin, immunotherapy, monoclonal antibodies, nanobodies, bispecific antibodies, checkpoint inhibitors, T-cell therapy, CAR-T, NK-cell therapy, macrophage modulation, immunomodulation, inflammation resolution, blood-brain barrier penetration, nanoparticle transport, receptor-mediated endocytosis, exocytosis, diffusion models, convection-enhanced delivery, targeted ultrasound, magnetic nanoparticles, optoacoustic delivery, biosensors, nanobiosensors, wearable sensors, implantable sensors, smart drug delivery, responsive nanoparticles, stimuli-responsive systems, pH-sensitive delivery, redox-sensitive delivery, enzyme-responsive carriers, light-triggered delivery, ultrasound-triggered delivery, temperature-sensitive delivery, programmable medicine, digital biomarkers, e-health, telemedicine, remote monitoring, AI diagnostics, clinical decision support, real-world evidence, population health, global burden, health economics, cost-effectiveness, ethical considerations, regulatory approval, FDA approval, EMA approval, MHRA approval, patent registration, intellectual property, open science, reproducible research, interdisciplinary collaboration, neuroscience consortia, translational medicine, personalised neurotherapeutics, futuristic medicine, integrative neuroscience, human brain project, connectomics, computational psychiatry, computational neurology, neural engineering, regenerative medicine, life extension, neuroenhancement, bioethics, transhumanism, neurophilosophy, cognitive liberty, consciousness studies, brain repair, neural resilience, ψ–Hamzah intellectual property, Seyed Rasoul Jalali, world scientific community, definitive cure, advanced validation, epochal breakthrough

  15. 15

    Source: Brain
    Brain : a journal of neurology
    r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
    Instituto de Investigación Sanitaria La Fe (IIS La Fe)
    BRAIN
    instname
    Brain, vol. 145, no. 5, pp. 1653-1667

    File Description: application/pdf; pdf

  16. 16
  17. 17
  18. 18
  19. 19
  20. 20